Kilitch Drugs (India) Limited

KILITCH

INE729D01010

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-07-01 EDT			5-day change	1st Jan Change
335.8 ^INR	+0.10%		+2.99%	-9.68%

05-27	Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-26	Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia	MT

Kilitch Drugs Limited Announces Resignation of Paresh Mehta as Jt. Managing Director and Director

April 19, 2016 at 07:27 am

Kilitch Drugs (India) Limited announced that Mr. Paresh Mehta has tendered his resignation as the Jt. Managing Director of the company and consequently he ceased to be the director of the company with effect from April 13, 2016.

Latest news about Kilitch Drugs (India) Limited

Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-27	CI
Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia	02-26	MT
Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals	02-23	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Kilitch Drugs Limited Announces Management Changes	22-05-27	CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-26	CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-26	CI
Bhavin Mehta completed the acquisition of 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.	22-04-21	CI
Kilitch Drugs Limited Announces Resignation of Princy Asati as Company Secretary & Compliance Officer	22-04-15	CI
Bhavin Mehta agreed to acquire 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.	22-04-11	CI
Kilitch Drugs Limited Commences New Facility Expansion Plan	22-03-04	CI
Kilitch Drugs (India) to Build Pharma Complex in Khopoli, India	22-03-03	MT
Kilitch Drugs Limited Announces Expansion of Manufacturing Facility at Khopoli	22-03-03	CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Kilitch Drugs Limited announced that it expects to receive INR 22.14375 million in funding	21-12-19	CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Kilitch Drugs Limited Announces Executive Changes	21-10-13	CI
Kilitch Drugs India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-13	CI

Chart Kilitch Drugs (India) Limited

Duration

Period

More charts

Company Profile

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Companyâs products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KILITCH DRUGS (INDIA) LIMITED	-9.68%	64.71M
ELI LILLY AND COMPANY	+56.51%	815B
NOVO NORDISK A/S	+43.90%	641B
JOHNSON & JOHNSON	-6.81%	352B
MERCK & CO., INC.	+17.61%	314B
ABBVIE INC.	+10.29%	303B
ASTRAZENECA PLC	+16.08%	242B
ROCHE HOLDING AG	+2.29%	224B
NOVARTIS AG	+13.96%	218B
AMGEN INC.	+8.35%	168B